KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Sales (2017 - 2025)

Historic Return on Sales for Amneal Pharmaceuticals (AMRX) over the last 9 years, with Q3 2025 value amounting to 0.02%.

  • Amneal Pharmaceuticals' Return on Sales rose 100.0% to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year increase of 700.0%. This contributed to the annual value of 0.03% for FY2024, which is 100.0% down from last year.
  • Per Amneal Pharmaceuticals' latest filing, its Return on Sales stood at 0.02% for Q3 2025, which was up 100.0% from 0.05% recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Return on Sales ranged from a high of 0.06% in Q2 2021 and a low of 0.43% during Q2 2022
  • Moreover, its 5-year median value for Return on Sales was 0.0% (2022), whereas its average is 0.03%.
  • Per our database at Business Quant, Amneal Pharmaceuticals' Return on Sales crashed by -4900bps in 2022 and then soared by 4800bps in 2023.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Return on Sales stood at 0.04% in 2021, then soared by 75bps to 0.01% in 2022, then crashed by -1476bps to 0.15% in 2023, then surged by 81bps to 0.03% in 2024, then soared by 181bps to 0.02% in 2025.
  • Its Return on Sales was 0.02% in Q3 2025, compared to 0.05% in Q2 2025 and 0.04% in Q1 2025.